Influenza Vaccine Allergy Clinical Trial
Official title:
Humoral and Cellular Immune Response Study of Influenza Vaccine
An observational clinical study will be performed in subjects aged 12-60 years old to describe the dynamic changes of humoral immune/cellular immunity after vaccination of influenza vaccine, and to discuss the role of different antibodies against influenza virus infection, and to look for possible factors related to side effects with the vaccine.
Status | Completed |
Enrollment | 207 |
Est. completion date | December 2012 |
Est. primary completion date | May 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 12 Years to 60 Years |
Eligibility |
Inclusion Criteria: - aged 12-60 years old - male or non-pregnant female - volunteers - clinically healthy as determined by: medical history inquiring and physical examination - provide written informed consents before joining the trial Exclusion Criteria: - infected with Influenza A virus subtype H1N1(2009), - vaccinated with seasonal influenza vaccine, - allergic to any ingredient of vaccine, - autoimmune disease or immunodeficiency, - active malignancy, - bleeding disorder, - seizure disorder, - Guillain-Barre Syndrome, - treatment with cytotoxic or immunosuppressive drugs within the past 6 months, - receipt of blood products within the past 3 months, - administration of any other investigational research agents or live attenuated vaccine within 30 days, - administration of subunit or inactivated vaccines within 14 days, - axillary temperature over 37.0? at the time of vaccination. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention, China |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the dynamic changes of humoral immune/cellular immunity after vaccination of influenza vaccine | one year | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06446232 -
Influenza Vaccine Effectiveness in Among Young Children in Taiwan
|
||
Completed |
NCT03654937 -
Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes
|
Phase 4 |